SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-13-068215
Filing Date
2013-12-19
Accepted
2013-12-19 17:03:51
Documents
3
Period of Report
2013-12-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v363414_8k.htm 8-K 15782
2 EXHIBIT 99.1 v363414_ex99-1.htm EX-99.1 9961
3 GRAPHIC tlogo.jpg GRAPHIC 19698
  Complete submission text file 0001144204-13-068215.txt   54217
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36179 | Film No.: 131288914
SIC: 2834 Pharmaceutical Preparations